A: New variants have been seen almost since the virus was first detected in China nearly a year ago. Viruses often mutate, or develop small changes, as they reproduce and move through a population.
Most changes are trivial. "It’s the change of one or two letters in the genetic alphabet that doesn’t make much difference in the ability to cause disease,” said Dr. Philip Landrigan, a former Centers for Disease Control and Prevention scientist who directs a global health program at Boston College.
A more concerning situation is when a virus mutates by changing the proteins on its surface to help it escape from drugs or the immune system, or if it acquires a lot of changes that make it very different from previous versions.
Q: HOW DOES ONE VARIANT BECOME DOMINANT?
A: That can happen if one variant takes hold and starts spreading in an area, or because “super spreader” events helped it become established.
It also can happen if a mutation gives a new variant an advantage, such as helping it spread more easily than other ones that are circulating.
Scientists are still working to confirm whether the variant in England spreads more easily, but they are finding some evidence that it does. The variant “out-competes the other strains and moves faster and infects more people, so it wins the race,” Landrigan said.
The British variant was first detected in September, WHO officials said. A new South African variant also has emerged.
Q: WHAT’S WORRISOME ABOUT THE BRITISH VARIANT?
A: It has many mutations — nearly two dozen — and eight are on the spike protein that the virus uses to attach to and infect cells. The spike is what vaccines and antibody drugs target.
Dr. Ravi Gupta, a virus expert at the University of Cambridge in England, said modeling studies suggest it may be up to two times more infectious than the version that's been most common in England so far. He and other researchers posted a report of it on a website scientists use to quickly share developments, but it has not been formally reviewed or published in a journal.
Q: DOES IT MAKE PEOPLE SICKER OR MORE LIKELY TO DIE?
A: “There’s no indication that either of those is true, but clearly those are two issues we’ve got to watch,” Landrigan said. As more patients get infected with the new variant, “they’ll know fairly soon if the new strain makes people sicker.”
A WHO outbreak expert, Maria Van Kerkhove, said “the information that we have so far is that there isn’t a change” in the kind of illness or its severity.
Q: WHAT DO THE MUTATIONS MEAN FOR TREATMENTS?
A: A couple of cases in England raise concern that the mutations in some of the emerging new variants could hurt the potency of drugs that supply antibodies to block the virus from infecting cells.
Studies on antibody response are underway, Van Kerkhove said.
One drugmaker, Eli Lilly, said tests in its lab suggest that its drug remains fully active.
Q: WHAT ABOUT VACCINES?
A: Scientists believe current vaccines will still be effective against the variant, but they are working to confirm that.
Vaccines induce broad immune system responses besides just prompting the immune system to make antibodies to the virus, so they are expected to still work, several scientists said.
Q: WHAT CAN I DO TO REDUCE MY RISK?
A: Follow the advice to wear a mask, wash your hands often, maintain social distance and avoid crowds, public health experts say.
“The bottom line is we need to suppress transmission” of the coronavirus, said the WHO’s director-general, Dr. Tedros Adhanom Ghebreyesus.
“The more we allow it to spread, the more mutations will happen.”